Press Release: CMG and Oxaliplatin studies for colon cancer

Press Release: CMG and Oxaliplatin studies for colon cancer

Therabiopharma (Japan Based Bio-Venture) Reports 10,000 Times Higher Curcumin Concentration in Bloodstream Clearly Demonstrates Strong Efficacies with/without Oxaliplatin in an Animal Study for Colon Cancer.